Olin Corp OLN
We take great care to ensure that the data presented and summarized in this overview for OLIN Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OLN
View all-
Black Rock Inc. New York, NY11.7MShares$476 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.5MShares$469 Million0.01% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA8.84MShares$361 Million1.48% of portfolio
-
State Street Corp Boston, MA4.73MShares$193 Million0.01% of portfolio
-
Boston Partners Boston, MA4.3MShares$176 Million0.26% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA4.08MShares$166 Million0.78% of portfolio
-
Donald Yacktman Yacktman Asset Management LP3.92MShares$160 Million2.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.8MShares$155 Million0.05% of portfolio
-
Richard Pzena Pzena Investment Management LLC3.45MShares$141 Million0.55% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.94MShares$120 Million0.07% of portfolio
Latest Institutional Activity in OLN
Top Purchases
Top Sells
About OLN
Olin Corporation manufactures and distributes chemical products in the United States, Europe, and internationally. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, chlorinated organics intermediates and solvents, and sodium hypochlorite. The Epoxy segment provides epoxy materials and precursors, including aromatics, such as acetone, bisphenol, cumene, and phenol, as well as allyl chloride, epichlorohydrin, and glycerin used for the manufacturers of polymers, resins and other plastic materials, and water purification; liquid and solid epoxy resins that are used in adhesives, marines, protective coatings, composites, and flooring; and converted epoxy resins and additives for use in electrical laminates, paints and coatings, wind blades, electronics, and construction. The Winchester segment offers sporting ammunition products, including shotshells, small caliber centerfire, and rimfire ammunition products for hunters and recreational shooters, and law enforcement agencies; small caliber military ammunition products for use in infantry and mounted weapons; and industrial products comprising gauge loads and powder-actuated tool loads for maintenance applications in power and concrete industries, and powder-actuated tools in construction industry. The company markets its products through its sales force, as well as directly to various industrial customers, mass merchants, retailers, wholesalers, other distributors, and the U.S. Government and its prime contractors. Olin Corporation was incorporated in 1892 and is based in Clayton, Missouri.
Insider Transactions at OLN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 08
2024
|
R Nichole Sumner VP & Controller |
SELL
Open market or private sale
|
Direct |
10,500
-30.39%
|
$451,500
$43.75 P/Share
|
Nov 08
2024
|
R Nichole Sumner VP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+23.3%
|
$283,500
$27.4 P/Share
|
May 01
2024
|
Carol A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
380
+5.47%
|
$19,760
$52.58 P/Share
|
May 01
2024
|
William H Weideman Director |
BUY
Grant, award, or other acquisition
|
Direct |
761
+5.47%
|
$39,572
$52.58 P/Share
|
May 01
2024
|
Julie A Piggott Director |
BUY
Grant, award, or other acquisition
|
Direct |
761
+50.0%
|
$39,572
$52.58 P/Share
|
May 01
2024
|
Beverley A Babcock Director |
BUY
Grant, award, or other acquisition
|
Direct |
761
+50.0%
|
$39,572
$52.58 P/Share
|
Feb 27
2024
|
Scott Mc Dougald Sutton President & CEO |
SELL
Open market or private sale
|
Direct |
48,896
-6.93%
|
$2,542,592
$52.43 P/Share
|
Feb 27
2024
|
Scott Mc Dougald Sutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
48,896
+25.99%
|
$1,369,088
$28.99 P/Share
|
Feb 27
2024
|
Brett A Flaugher VP & Pres, Winchester |
SELL
Open market or private sale
|
Indirect |
10,000
-11.39%
|
$520,000
$52.2 P/Share
|
Feb 26
2024
|
Scott Mc Dougald Sutton President & CEO |
SELL
Open market or private sale
|
Direct |
16,924
-5.52%
|
$880,048
$52.58 P/Share
|
Feb 26
2024
|
Scott Mc Dougald Sutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,924
+13.63%
|
$473,872
$28.99 P/Share
|
Feb 26
2024
|
Brett A Flaugher VP & Pres, Winchester |
SELL
Open market or private sale
|
Direct |
15,000
-63.07%
|
$780,000
$52.46 P/Share
|
Feb 26
2024
|
Brett A Flaugher VP & Pres, Winchester |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+38.68%
|
$195,000
$13.14 P/Share
|
Feb 23
2024
|
Scott Mc Dougald Sutton President & CEO |
SELL
Open market or private sale
|
Direct |
21,946
-8.14%
|
$1,141,192
$52.67 P/Share
|
Feb 22
2024
|
Scott Mc Dougald Sutton President & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-5.87%
|
$780,000
$52.5 P/Share
|
Feb 22
2024
|
Damian Gumpel VP Corp Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
8,782
+20.27%
|
-
|
Feb 21
2024
|
Scott Mc Dougald Sutton President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
88,244
+49.42%
|
-
|
Feb 21
2024
|
R Nichole Sumner VP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
4,263
+15.05%
|
-
|
Feb 21
2024
|
Valerie A Peters VP, HR |
BUY
Grant, award, or other acquisition
|
Direct |
8,782
+32.17%
|
-
|
Feb 21
2024
|
Teresa M Vermillion VP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,666
+18.57%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 144K shares |
---|---|
Exercise of conversion of derivative security | 932K shares |
Open market or private sale | 877K shares |
---|---|
Payment of exercise price or tax liability | 194K shares |